Sei Investments Co. Invests $330,000 in Simulations Plus, Inc. (NASDAQ:SLP)

Sei Investments Co. purchased a new stake in Simulations Plus, Inc. (NASDAQ:SLP) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 11,835 shares of the technology company’s stock, valued at approximately $330,000. Sei Investments Co. owned 0.06% of Simulations Plus as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Quantbot Technologies LP increased its holdings in Simulations Plus by 191.6% during the 4th quarter. Quantbot Technologies LP now owns 5,371 shares of the technology company’s stock worth $150,000 after purchasing an additional 3,529 shares during the period. Nicholas Company Inc. purchased a new stake in shares of Simulations Plus in the 4th quarter valued at approximately $3,418,000. Royce & Associates LP raised its holdings in shares of Simulations Plus by 56.6% in the 4th quarter. Royce & Associates LP now owns 371,797 shares of the technology company’s stock valued at $10,369,000 after purchasing an additional 134,381 shares in the last quarter. Natixis Advisors LLC acquired a new position in shares of Simulations Plus during the fourth quarter worth $288,000. Finally, AlphaQuest LLC increased its holdings in Simulations Plus by 502.9% in the fourth quarter. AlphaQuest LLC now owns 2,689 shares of the technology company’s stock valued at $75,000 after buying an additional 2,243 shares during the last quarter. Institutional investors and hedge funds own 78.08% of the company’s stock.

Insider Transactions at Simulations Plus

In related news, Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $33.91, for a total transaction of $678,200.00. Following the completion of the transaction, the director now directly owns 3,402,584 shares in the company, valued at $115,381,623.44. The trade was a 0.58 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 19.40% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have recently commented on SLP. StockNews.com upgraded Simulations Plus from a “sell” rating to a “hold” rating in a report on Friday, April 4th. William Blair restated an “outperform” rating on shares of Simulations Plus in a research report on Wednesday, January 8th. Finally, KeyCorp boosted their price target on shares of Simulations Plus from $35.00 to $37.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Two investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $49.40.

Simulations Plus Stock Performance

Shares of SLP opened at $25.74 on Friday. The firm has a 50-day simple moving average of $28.94 and a 200-day simple moving average of $30.02. The company has a market capitalization of $517.17 million, a price-to-earnings ratio of 64.35 and a beta of 1.13. Simulations Plus, Inc. has a fifty-two week low of $23.01 and a fifty-two week high of $51.22.

Simulations Plus (NASDAQ:SLP) last released its quarterly earnings results on Thursday, April 3rd. The technology company reported $0.31 EPS for the quarter, topping the consensus estimate of $0.25 by $0.06. The business had revenue of $22.43 million during the quarter, compared to analysts’ expectations of $21.93 million. Simulations Plus had a return on equity of 6.84% and a net margin of 10.97%. The company’s quarterly revenue was up 22.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.20 earnings per share. Equities research analysts forecast that Simulations Plus, Inc. will post 1.09 EPS for the current year.

Simulations Plus Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.